Metrics to compare | 600812 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600812PeersSector | |
|---|---|---|---|---|
P/E Ratio | 52.3x | 18.3x | −0.3x | |
PEG Ratio | −22.92 | 0.45 | 0.00 | |
Price/Book | 1.5x | 1.7x | 2.6x | |
Price / LTM Sales | 1.0x | 1.5x | 3.1x | |
Upside (Analyst Target) | - | 29.4% | 47.6% | |
Fair Value Upside | Unlock | 28.5% | 5.6% | Unlock |
North China Pharmaceutical Company.Ltd engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company primarily offers anti-infective, biotechnology, and cardiovascular cerebrovascular drugs; and immunomodulators, vitamins, and health products. It also provides chemical, biological, agricultural, and biopharmaceuticals and veterinary drugs. It serves pharmaceutical distributors, agents, hospitals, chain pharmacies, and end-user clinics. North China Pharmaceutical Company.Ltd was founded in 1992 and is headquartered in Shijiazhuang, China.